Fred G Weiss
CIK 1081534 · last filed 2021-09-03
Fred G Weiss is a corporate insider who has filed 26 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $18.2K of OSMT on Sep 3, 2021. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions. 10 SEC filings were submitted jointly with Actavis plc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WPI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PRINCETON, NJ 08536
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc (OSMT) Delisted | Director | 118,466 | $1.11 | $131.5K | $0 | 8 | 2021-09-03 |
| Allergan plc (AGN) Delisted | Director | 29,675 | — | — | $0 | 5 | 2018-05-04 |
| ACT | Director | 24,868 | $47.68 | $1.19M | $0 | 2 | 2015-06-08 |
| Actavis, Inc. (WPI) Delisted | Director | 55,398 | — | — | -$3.89M | 8 | 2012-07-31 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-03 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −5,506 | -$18.2K | EDGAR |
| 2021-07-07 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | +61,188 | $0 | EDGAR |
| 2021-06-22 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −18,584 | -$53.7K | EDGAR |
| 2021-01-26 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −5,505 | -$24.6K | EDGAR |
| 2020-05-22 | RVL Pharmaceuticals plc (OSMT) Delisted | Mixed | +20,938 | -$81.8K | EDGAR |
| 2020-01-30 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −5,505 | -$38.5K | EDGAR |
| 2019-06-19 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | +37,037 | $0 | EDGAR |
| 2019-01-28 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | +34,403 | $0 | EDGAR |
| 2018-05-04 | Allergan plc (AGN) Delisted | Grant (A) | +1,985 | $299.9K | EDGAR |
| 2017-05-05 | Allergan plc (AGN) Delisted | Mixed | +555 | $137.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.